Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women.

Jean Ngou ; Mahlape P Magooa ; Clare Gilham ORCID logo ; Florencia Djigma ; Marie-Noelle Didelot ; Helen Kelly ORCID logo ; Albert Yonli ; Bernard Sawadogo ; David A Lewis ; Sinead Delany-Moretlwe ; +3 more... Philippe Mayaud ORCID logo ; Michel Segondy ; HARP Study Group ; (2013) Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women. Journal of clinical microbiology, 51 (12). pp. 4240-4242. ISSN 0095-1137 DOI: 10.1128/JCM.02144-13
Copy

The careHPV and HC2 assays were compared for high-risk human papillomavirus (HR-HPV) DNA detection in cervical samples from 149 HIV-1-infected African women. The HR-HPV DNA detection rates were 37.6% and 34.9% for careHPV and HC2, respectively. Agreement between the two tests was 94.6% (95% confidence interval [CI], 89.7% to 97.7%) with a kappa value of 0.88 (95% CI, 0.81 to 0.96), indicating an excellent agreement. careHPV may be considered as suitable as HC2 for cervical cancer screening among HIV-infected African women.
Item Type Article
ISI 327147100062
Date Deposited 23 Oct 2013 19:05

Explore Further

picture_as_pdf
J. Clin. Microbiol.-2013-Ngou-JCM.02144-13.pdf
subject
Accepted Version
Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads